cannabinoids control spasticity tremor multiple sclerosis model 
chronic relapsing experimental allergic encephalomyelitis creae autoimmune model multiple sclerosis although diseases typified relapsing-remitting paralytic episodes creae induction sensitization myelin antigens biozzi abh mice also develop spasticity tremor symptoms also occur multiple sclerosis difficult control prompted patients find alternative medicines perceive benefit cannabis use although benefit backed small clinical studies mainly non-quantifiable outcomes- value cannabis use multiple sclerosis remains anecdotal show cannabinoid cb receptor agonism using r+-win delta-tetrahydrocannabinol methanandamide jwh ref quantitatively ameliorated tremor spasticity diseased mice exacerbation signs antagonism cb cb receptors notably cb receptor using sr141716a sr144528 ref indicative endogenous cannabinoid system may tonically active control tremor spasticity provides rationale patients indications therapeutic potential cannabis control symptoms multiple sclerosis provides means evaluating selective cannabinoids future 
